Lung Cancer Management

Isla D, Massuti B, Lázaro M, Ruiz de Alda L, Gordo R, Ortega-Joaquín N, Oyagüez I

 

 

Cost analysis of the management of brain metastases in patients with advanced ALK+ NSCLC: alectinib versus crizotinib

Lung Cancer Management 2020. doi.org/10.2217/lmt-2019-0011